|
【结 构 式】 
|
【分子编号】17380 【品名】(2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid 【CA登记号】3105-95-1 |
【 分 子 式 】C6H11NO2 【 分 子 量 】129.15888 【元素组成】C 55.8% H 8.58% N 10.84% O 24.77% |
合成路线1
该中间体在本合成路线中的序号：(XII)The diastereoselective reduction of (VII) with NaBH4/CeCl3 in methanol/ethyl ether affords alcohol (VIII), which was methylated with trimethyloxonium tetrafluoroborate in dichloromethane giving the methyl ether (IX). The treatment of (IX) with lithium bis(trimethylsilyl)amide (Li-HMDS) and Mg(HMDS)2 causes enolization and ring opening affording alcohol (X), which was protected with tert-butyldimethylsilyl triflate yielding the fully silylated compound (XI). The hydrolysis of the ester group of (XI) with NaOH, followed by a selective elimination of the triethylsilyl group with trifluoroacetic acid and esterification of the resulting alcohol with piperidine-2(S)-carboxylic acid (XII) by means of dicyclohexylcarbodiimide (DCC) and dimethylaminopyridine (DMAP) afforded ester (XIII).
| 【1】 Liu, L.B.; Roper, T.D.; Gleason, J.L.; Ireland, R.E.; Total synthesis of FK-506. 2. Completion of the synthesis. Tetrahedron 1997, 53, 39, 13257. |
| 【2】 Liu, L.B.; Roper, T.D.; Ireland, R.E.; Total synthesis of FK-506. 1. Construction of the C16-C34 fragment. Tetrahedron 1997, 53, 39, 13221. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (VII) | 17375 | ethyl (4R,5S,7S,8S,10R)-7-((3S,5E)-6-[4-[(1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[(triethylsilyl)oxy]-3-butenyl]-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-3,5-dimethyl-5-hexenoyl)-8-methoxy-2,2,10-trimethyl-1,3,6-trioxaspiro[4.5]decane-4-carboxylate | C75H114O15Si2 | 详情 | 详情 | |
| (VIII) | 17376 | ethyl (4R,5S,7R,8S,10R)-7-((1S,3S,5E)-6-[4-[(1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[(triethylsilyl)oxy]-3-butenyl]-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-1-hydroxy-3,5-dimethyl-5-hexenyl)-8-methoxy-2,2,10-trimethyl-1,3,6-trioxaspiro[4.5]decane-4-carboxylate | C75H116O15Si2 | 详情 | 详情 | |
| (IX) | 17377 | ethyl (4R,5S,7R,8S,10R)-7-((1S,3S,5E)-6-[4-[(1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[(triethylsilyl)oxy]-3-butenyl]-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-1-methoxy-3,5-dimethyl-5-hexenyl)-8-methoxy-2,2,10-trimethyl-1,3,6-trioxaspiro[4.5]decane-4-carboxylate | C76H118O15Si2 | 详情 | 详情 | |
| (X) | 17378 | ethyl 5-((1R,3S,4R,5S,7S,9E)-10-[4-[(1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[(triethylsilyl)oxy]-3-butenyl]-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-4-hydroxy-3,5-dimethoxy-1,7,9-trimethyl-9-decenyl)-2,2-dimethyl-1,3-dioxole-4-carboxylate | C76H118O15Si2 | 详情 | 详情 | |
| (XI) | 17379 | ethyl 5-((1R,3S,4R,5S,7S,9E)-4-[[tert-butyl(dimethyl)silyl]oxy]-10-[4-[(1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[(triethylsilyl)oxy]-3-butenyl]-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-3,5-dimethoxy-1,7,9-trimethyl-9-decenyl)-2,2-dimethyl-1,3-dioxole-4-carboxylate | C82H132O15Si3 | 详情 | 详情 | |
| (XII) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (XIII) | 17381 | 5-((1R,3S,4R,5S,7S,9E)-4-[[tert-butyl(dimethyl)silyl]oxy]-10-[4-((1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[[(2S)piperidinylcarbonyl]oxy]-3-butenyl)-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-3,5-dimethoxy-1,7,9-trimethyl-9-decenyl)-2,2-dimethyl-1,3-dioxole-4-carboxylic acid | C80H123NO16Si2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(II)Optical resolution of DL-pipecolinic acid (I) with (+)-tartaric acid gives L-pipecolinic acid (II), which is treated with PCl5 to obtain acil chloride (III). This compound is condensed with 2,5-dimethylaniline (IV) by means N-methylpirrolidine (NMP) to afford amide (V). Finally, amide (V) is alkylated with 1-bromopropane by means potassium carbonate (K2CO3) to yield Ropivacaine.
| 【1】 Sandeberg, R.V. (AstraZeneca plc); S-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it. EP 0239710; US 4870086 . |
| 【2】 T. af Ekenstam, B.; Bovin, C. (Alpharma Inc.); L-N-n-Propylpipecolic acid-2,6-xylidide and method for preparing the same. JP 1985502054; WO 8500599 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 17532 | 2-piperidinecarboxylic acid; pipecolic acid | 535-75-1 | C6H11NO2 | 详情 | 详情 |
| (II) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (III) | 19499 | (2S)-2-piperidinecarbonyl chloride | C6H10ClNO | 详情 | 详情 | |
| (IV) | 17527 | 2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine | 87-62-7 | C8H11N | 详情 | 详情 |
| (V) | 17531 | (2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide | C14H20N2O | 详情 | 详情 | |
| (VI) | 19502 | Propyl bromide; 1-Bromopropane | 106-94-5 | C3H7Br | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号：(II)L-Picolinic acid (II) is protected with benzyl chloroformiate (VII) to afford compound (VIII), which is condensed with 2-methylaniline (IX) by means SOCl2/DMAP to yield amide (X). This compound (X) is methylated by treatment with palladium acetate (Pd(Oac)2) to obtain compound (XI), which is deprotected by means HBr to yield compound (V). Finally, this compound (V) is alkylated with 1-iodopropane by means potassium carbonate (K2CO3) to yield Ropivacaine.
| 【1】 Sandeberg, R.V. (AstraZeneca plc); S-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it. EP 0239710; US 4870086 . |
| 【2】 T. af Ekenstam, B.; Bovin, C. (Alpharma Inc.); L-N-n-Propylpipecolic acid-2,6-xylidide and method for preparing the same. JP 1985502054; WO 8500599 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| 28758 | 1-iodopropane | 107-08-4 | C3H7I | 详情 | 详情 | |
| (II) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (V) | 17531 | (2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide | C14H20N2O | 详情 | 详情 | |
| (VII) | 10101 | Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene | 501-53-1 | C8H7ClO2 | 详情 | 详情 |
| (VIII) | 19504 | (2S)-1-[(benzyloxy)carbonyl]-2-piperidinecarboxylic acid | C14H17NO4 | 详情 | 详情 | |
| (IX) | 15511 | o-toluidine; 2-methylphenylamine;2-Methylaniline；2-Aminotoluene;1-Amino-2-methylbenzene;1-Methyl-2-aminobenzene; ortho-Toluidine | 95-53-4 | C7H9N | 详情 | 详情 |
| (X) | 19506 | benzyl (2S)-2-(2-toluidinocarbonyl)-1-piperidinecarboxylate | C21H24N2O3 | 详情 | 详情 | |
| (XI) | 19507 | benzyl (2S)-2-[(2,6-dimethylanilino)carbonyl]-1-piperidinecarboxylate | C22H26N2O3 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号：(II)1) The optical resolution of pipecolic acid (I) with (+)-tartaric acid in water-ethanol gives L-pipecolic acid (II), which by reaction with Cl5P in acetyl chloride is converted to the acyl chloride (III). The condensation of (III) with 2,6-xylidine (IV) by means of N-methylpyrrolidone (NMP) in acetone affords L-pipecolic acid 2,6-xylidide (V), which is finally alkylated with propyl bromide (VI) and K2CO3 in hot isopropanol.
| 【1】 T. af Ekenstam, B.; Bovin, C. (Astra Lakemedel AB); L-N-n-Propylpipecolic acid 2,6-xylidide. US 4695576 . |
| 【2】 Prous, J.; Castaner, J.; ROPIVACAINE HYDROCHLORIDE < Rec INNM >. Drugs Fut 1989, 14, 8, 767. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 17532 | 2-piperidinecarboxylic acid; pipecolic acid | 535-75-1 | C6H11NO2 | 详情 | 详情 |
| (II) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (III) | 19499 | (2S)-2-piperidinecarbonyl chloride | C6H10ClNO | 详情 | 详情 | |
| (IV) | 17527 | 2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine | 87-62-7 | C8H11N | 详情 | 详情 |
| (V) | 17531 | (2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide | C14H20N2O | 详情 | 详情 | |
| (VI) | 19502 | Propyl bromide; 1-Bromopropane | 106-94-5 | C3H7Br | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号：(II)2) The protection of L-pipecolic acid (II) with benzyl chloroformate (VII) gives the benzyloxycarbonyl compound (VIII), which is condensed with o-toluidine (IX) by means of SOCl2 and dimethylaminopyridine (DMAP) yielding the amide (X). The methylation of (X) with methyl iodide and palladium diacetate in acetic acid affords the 2,6-xylidide (XI), which is deprotected with HBr in acetic acid to give L-pipecolic acid 2,6-xylidide (V). Finally, this compound is alkylated with propyl iodide and K2CO3 in acetonitrile.
| 【1】 Prous, J.; Castaner, J.; ROPIVACAINE HYDROCHLORIDE < Rec INNM >. Drugs Fut 1989, 14, 8, 767. |
| 【2】 Sahlberg, C.; Synthesis of carbon-14 labelled ropivacaine, a local anaesthetic agent. J Label Compd Radiopharm 1987, 24, 5, 529. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (II) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (V) | 17531 | (2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide | C14H20N2O | 详情 | 详情 | |
| (VI) | 19502 | Propyl bromide; 1-Bromopropane | 106-94-5 | C3H7Br | 详情 | 详情 |
| (VII) | 10101 | Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene | 501-53-1 | C8H7ClO2 | 详情 | 详情 |
| (VIII) | 19504 | (2S)-1-[(benzyloxy)carbonyl]-2-piperidinecarboxylic acid | C14H17NO4 | 详情 | 详情 | |
| (IX) | 15511 | o-toluidine; 2-methylphenylamine;2-Methylaniline；2-Aminotoluene;1-Amino-2-methylbenzene;1-Methyl-2-aminobenzene; ortho-Toluidine | 95-53-4 | C7H9N | 详情 | 详情 |
| (X) | 19506 | benzyl (2S)-2-(2-toluidinocarbonyl)-1-piperidinecarboxylate | C21H24N2O3 | 详情 | 详情 | |
| (XI) | 19507 | benzyl (2S)-2-[(2,6-dimethylanilino)carbonyl]-1-piperidinecarboxylate | C22H26N2O3 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号：(II)The compound has been obtained biosynthetically by an optimized fermentation process using Streptomyces hygroscopicus mutant RSH 1701 with a complex culture medium were [14C]-labeled (1R,3R,4R)-2,3-dichydroxycyclo-hexanecarboxylic acid (I) and [14C]-labeled (S)-pipecolic acid (II) have been added. This fermentation process yielded [14C]-labeled rapamycin (III), which was finally selectively O-alkylated at the C-40 position with monosilylated ethylene glycol triflate in DMSO/dimethoxyethane.
| 【1】 Moenius, T.; et al.; C-14 labelling of NVP RAD001 - A new rapamycin derivative. J Label Compd Radiopharm 1999, 42, 1, 29. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 32019 | (1R,3R,4R)-3,4-dihydroxycyclohexanecarboxylic acid | C7H12O4 | 详情 | 详情 | |
| (I) | 45302 | (1R,3R,4R)-3,4-dihydroxycyclohexanecarboxylic acid | C7H12O4 | 详情 | 详情 | |
| (II) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (II) | 45303 | (2S)-2-piperidinecarboxylic acid | C6H11NO2 | 详情 | 详情 | |
| (III) | 20296 | (1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone | 53123-88-9 | C51H79NO13 | 详情 | 详情 |
| (III) | 45304 | (1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2 | C51H79NO13 | 详情 | 详情 |
合成路线7
该中间体在本合成路线中的序号：(II)The reaction of the labeled acylated (-)-bornane-10,2-sultam (XI) with benzophenone imine (XII) gives the glycylsultam derivative (XIII), which is alkylated with 4-iodobutyl chloride (XIV) by means of butyllithium and DMPU in THF yielding intermediate (XV). The selective hydrolysis of (XV) with HCl affords the omega-chloro-L-norleucine derivative (XVI), which is cyclized by means of tetrabutylammonium fluoride and DIEA in hot acetonitrile giving the (2S)-piperidyl derivative (XVII). Finally, this compound is hydrolyzed with LiOH in THF/water to the labeled intermediate (II).
| 【1】 Moenius, T.; et al.; C-14 labelling of NVP RAD001 - A new rapamycin derivative. J Label Compd Radiopharm 1999, 42, 1, 29. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (II) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (II) | 45303 | (2S)-2-piperidinecarboxylic acid | C6H11NO2 | 详情 | 详情 | |
| (XI) | 32030 | (1R,5R)-4-(2-bromoacetyl)-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C12H18BrNO3S | 详情 | 详情 | |
| (XI) | 45315 | (1R,5R)-4-(2-bromoacetyl)-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C12H18BrNO3S | 详情 | 详情 | |
| (XII) | 32024 | diphenylmethanimine | 1013-88-3 | C13H11N | 详情 | 详情 |
| (XIII) | 32025 | (1R,5R)-4-[2-[(dibenzylene)amino]acetyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C25H28N2O3S | 详情 | 详情 | |
| (XIII) | 45311 | (1R,5R)-4-[2-[(dibenzylene)amino]acetyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C25H28N2O3S | 详情 | 详情 | |
| (XIV) | 32026 | 1-chloro-4-iodobutane | 10297-05-9 | C4H8ClI | 详情 | 详情 |
| (XV) | 32027 | (1R,5R)-4-[(2S)-6-chloro-2-[(dibenzylene)amino]hexanoyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C29H35ClN2O3S | 详情 | 详情 | |
| (XV) | 45312 | (1R,5R)-4-[(2S)-6-chloro-2-[(dibenzylene)amino]hexanoyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C29H35ClN2O3S | 详情 | 详情 | |
| (XVI) | 32028 | (1R,5R)-4-[(2S)-2-amino-6-chlorohexanoyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C16H27ClN2O3S | 详情 | 详情 | |
| (XVI) | 45313 | (1R,5R)-4-[(2S)-2-amino-6-chlorohexanoyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C16H27ClN2O3S | 详情 | 详情 | |
| (XVII) | 32029 | (1R,5R)-10,10-dimethyl-4-[(2S)piperidinylcarbonyl]-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C16H26N2O3S | 详情 | 详情 | |
| (XVII) | 45314 | (1R,5R)-10,10-dimethyl-4-[(2S)piperidinylcarbonyl]-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione | C16H26N2O3S | 详情 | 详情 |
合成路线8
该中间体在本合成路线中的序号：(XXVI)In a related method, L-pipecolic acid (XXVI) was protected as the methyl carbamate, followed by esterification with isobutylene to give (XXVII). Oxidation of (XXVII) with NaIO4 in the presence of RuO2 generated the 6-oxopipecolic acid derivative (XXVIII), which was subsequently methylated to yield (XXIX) as the major diastereoisomer. Reduction of (XXIX) with DIBAL afforded the cyclic aminal (XXX). Condensation of (XXX) with methyl L-cysteinate (VIII) gave thiazolidine (XXXIa-b). After tert-butyl ester cleavage in (XXXIa-b) with trifluoroacetic acid, cyclization by means of EEDQ produced the bicyclic system (XXXII). Deprotection of the methyl carbamate group of (XXXII) was carried out using methanesulfonic acid in the presence of dimethyl sulfide to afford amine (XXXIII). Coupling of (XXXIII) with (2S,3S)-2-acetylthio-3-methylpentanoic acid (XII) gave the corresponding mixture of amides, from which the desired isomer (XIII) was isolated by column chromatography. Finally, hydrolysis of methyl ester and tioacetate ester groups of (XIII) using LiOH gave rise to the title compound.
| 【1】 Oinuma, H.; Kotake, M.; Suda, S.; et al.; Discovery of a novel and orally active dual inhibitor of NEP and ACE: Synthesis and pharmacology. 217th ACS Natl Meet (March 21 1999, Anaheim) 2000, Abst MEDI 111. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (XXXIa) | 38528 | methyl (2R,4R)-2-[(1R,4S)-5-(tert-butoxy)-4-[(methoxycarbonyl)amino]-1-methyl-5-oxopentyl]-1,3-thiazolidine-4-carboxylate | C17H30N2O6S | 详情 | 详情 | |
| (XXXIb) | 38529 | methyl (2S,4R)-2-[(1R,4S)-5-(tert-butoxy)-4-[(methoxycarbonyl)amino]-1-methyl-5-oxopentyl]-1,3-thiazolidine-4-carboxylate | C17H30N2O6S | 详情 | 详情 | |
| (VIII) | 27413 | methyl (2R)-2-amino-3-sulfanylpropanoate | C4H9NO2S | 详情 | 详情 | |
| (XII) | 35122 | (2S,3S)-2-(acetylsulfanyl)-3-methylpentanoic acid | C8H14O3S | 详情 | 详情 | |
| (XIII) | 38523 | methyl (3R,6S,9R,9aR)-6-[[(2S,3S)-2-(acetylsulfanyl)-3-methylpentanoyl]amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C19H30N2O5S2 | 详情 | 详情 | |
| (XXVI) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (XXVII) | 38524 | 2-(tert-butyl) 1-methyl (2S)-1,2-piperidinedicarboxylate | C12H21NO4 | 详情 | 详情 | |
| (XXVIII) | 38525 | 2-(tert-butyl) 1-methyl (2S)-6-oxo-1,2-piperidinedicarboxylate | C12H19NO5 | 详情 | 详情 | |
| (XXIX) | 38526 | 2-(tert-butyl) 1-methyl (2S,5R)-5-methyl-6-oxo-1,2-piperidinedicarboxylate | C13H21NO5 | 详情 | 详情 | |
| (XXX) | 38527 | 2-(tert-butyl) 1-methyl (2S,5R)-6-hydroxy-5-methyl-1,2-piperidinedicarboxylate | C13H23NO5 | 详情 | 详情 | |
| (XXXII) | 38530 | methyl (3R,6S,9R,9aR)-6-[(methoxycarbonyl)amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C13H20N2O5S | 详情 | 详情 | |
| (XXXIII) | 38521 | methyl (3R,6S,9R,9aR)-6-amino-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C11H18N2O3S | 详情 | 详情 |
合成路线9
该中间体在本合成路线中的序号：(I)(S)-Pipecolinic acid (I) was protected as the Fmoc-derivative (II) using 9-fluorenylmethyl chloroformate and Na2CO3. Subsequent coupling of (II) with O-(tert-butyldiphenylsilyl)hydroxylamine (III) by means of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) provided the silyl hydroxamate (IV). Removal of the Fmoc group of (IV) was then achieved by treatment with diethylamine in THF to provide (V). Treatment of N-(2-pyridyl)piperazine (VI) with chlorosulfonic acid and then with phosphorus pentachloride afforded the sulfamyl chloride (VII). This was coupled with piperidine (V) in the presence of Et3N to yield the sulfamide derivative (VIII). Finally, removal of the silyl protecting group of (VIII) was carried out with tetrabutylammonium fluoride in CH2Cl2.
| 【1】 Mitchell, L.J. Jr.; Burke, B.; Dagostino, E.; et al.; Novel sulfamides and sulfonamide inhibitors of matrix metalloproteases. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 76. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (II) | 25357 | (2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-piperidinecarboxylic acid | C21H21NO4 | 详情 | 详情 | |
| (III) | 33013 | O-[tert-butyl(diphenyl)silyl]hydroxylamine; (aminooxy)(tert-butyl)diphenylsilane | C16H21NOSi | 详情 | 详情 | |
| (IV) | 33009 | 9H-fluoren-9-ylmethyl (2R)-2-[([[tert-butyl(diphenyl)silyl]oxy]amino)carbonyl]-1-piperidinecarboxylate | C37H40N2O4Si | 详情 | 详情 | |
| (V) | 33010 | (2R)-N-[[tert-butyl(diphenyl)silyl]oxy]-2-piperidinecarboxamide | C22H30N2O2Si | 详情 | 详情 | |
| (VI) | 24399 | 1-(2-pyridinyl)piperazine | 34803-66-2 | C9H13N3 | 详情 | 详情 |
| (VII) | 33011 | 4-(2-pyridinyl)-1-piperazinesulfonyl chloride | C9H12ClN3O2S | 详情 | 详情 | |
| (VIII) | 33012 | (2R)-N-[[tert-butyl(diphenyl)silyl]oxy]-1-[[4-(2-pyridinyl)-1-piperazinyl]sulfonyl]-2-piperidinecarboxamide | C31H41N5O4SSi | 详情 | 详情 |
合成路线10
该中间体在本合成路线中的序号：(I)(S)-Pipecolinic acid (I) was protected as the Fmoc-derivative (II) using 9-fluorenylmethyl chloroformate and Na2CO3. Subsequent coupling of (II) with O-(tert-butyldiphenylsilyl)hydroxylamine (III) by means of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) provided the silyl hydroxamate (IV). Removal of the Fmoc group of (IV) was then achieved by treatment with diethylamine in THF to provide (V). Treatment of 4-[4-(imidazol-1-yl)phenoxy]piperidine (VI) with chlorosulfonic acid and then with phosphorus pentachloride afforded the sulfamyl chloride (VII). This was coupled with piperidine (V) in the presence of Et3N to yield the sulfamide derivative (VIII). Finally, removal of the silyl protecting group of (VIII) was carried out with tetrabutylammonium fluoride in CH2Cl2.
| 【1】 Mitchell, L.J. Jr.; Burke, B.; Dagostino, E.; et al.; Novel sulfamides and sulfonamide inhibitors of matrix metalloproteases. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 76. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (II) | 25337 | (1S,2S,3R,4S,7R,9S,10R,12R,15S)-4,12-bis(acetoxy)-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[1 | C70H85NO17Si | 详情 | 详情 | |
| (III) | 33013 | O-[tert-butyl(diphenyl)silyl]hydroxylamine; (aminooxy)(tert-butyl)diphenylsilane | C16H21NOSi | 详情 | 详情 | |
| (IV) | 33009 | 9H-fluoren-9-ylmethyl (2R)-2-[([[tert-butyl(diphenyl)silyl]oxy]amino)carbonyl]-1-piperidinecarboxylate | C37H40N2O4Si | 详情 | 详情 | |
| (V) | 33010 | (2R)-N-[[tert-butyl(diphenyl)silyl]oxy]-2-piperidinecarboxamide | C22H30N2O2Si | 详情 | 详情 | |
| (VI) | 33014 | 4-[4-(1H-imidazol-1-yl)phenoxy]piperidine; 4-(1H-imidazol-1-yl)phenyl 4-piperidinyl ether | C14H17N3O | 详情 | 详情 | |
| (VII) | 33015 | 4-[4-(1H-imidazol-1-yl)phenoxy]-1-piperidinesulfonyl chloride | C14H16ClN3O3S | 详情 | 详情 | |
| (VIII) | 33016 | (2R)-N-[[tert-butyl(diphenyl)silyl]oxy]-1-([4-[4-(1H-imidazol-1-yl)phenoxy]-1-piperidinyl]sulfonyl)-2-piperidinecarboxamide | C36H45N5O5SSi | 详情 | 详情 |
合成路线11
该中间体在本合成路线中的序号：(XIV)In a related method, L-pipecolic acid (XIV) was protected as the methyl carbamate, followed by esterification with isobutylene to give (XV). Oxidation of (XV) with NaIO4 in the presence of RuO2 generated the 6-oxopipecolic acid derivative (XVI), which was subsequently methylated to yield (XVII) as the major diastereoisomer. Reduction of (XVII) with DIBAL afforded the cyclic aminal (XVIII). Condensation of (XVIII) with methyl L-cysteinate (VIII) gave thiazolidine (XIXa-b). After tert-butyl ester cleavage in (XIXa-b) with trifluoroacetic acid, cyclization by means of EEDQ produced the bicyclic system (XX). Deprotection of the methyl carbamate group of (XX) was carried out using methanesulfonic acid in the presence of dimethyl sulfide to afford amine (XXI). Coupling of (XXI) with (2S,3S)-2-acetylthio-3-methylpentanoic acid (XII) gave the corresponding mixture of amides, from which the desired isomer (XIII) was isolated by column chromatography. Hydrolysis of methyl ester and thioacetate ester groups of (XIII) using LiOH, followed by S-acetylation with Ac2O in the presence of CoCl2 gave rise to the title compound.
| 【1】 Oinuma, H.; Kotake, M.; Suda, S.; et al.; Discovery of a novel and orally active dual inhibitor of NEP and ACE: Synthesis and pharmacology. 217th ACS Natl Meet (March 21 1999, Anaheim) 2000, Abst MEDI 111. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (XIXa) | 38528 | methyl (2R,4R)-2-[(1R,4S)-5-(tert-butoxy)-4-[(methoxycarbonyl)amino]-1-methyl-5-oxopentyl]-1,3-thiazolidine-4-carboxylate | C17H30N2O6S | 详情 | 详情 | |
| (XIXb) | 38529 | methyl (2S,4R)-2-[(1R,4S)-5-(tert-butoxy)-4-[(methoxycarbonyl)amino]-1-methyl-5-oxopentyl]-1,3-thiazolidine-4-carboxylate | C17H30N2O6S | 详情 | 详情 | |
| (VIII) | 27413 | methyl (2R)-2-amino-3-sulfanylpropanoate | C4H9NO2S | 详情 | 详情 | |
| (XII) | 35122 | (2S,3S)-2-(acetylsulfanyl)-3-methylpentanoic acid | C8H14O3S | 详情 | 详情 | |
| (XIII) | 38523 | methyl (3R,6S,9R,9aR)-6-[[(2S,3S)-2-(acetylsulfanyl)-3-methylpentanoyl]amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C19H30N2O5S2 | 详情 | 详情 | |
| (XIV) | 17380 | (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid | 3105-95-1 | C6H11NO2 | 详情 | 详情 |
| (XV) | 38524 | 2-(tert-butyl) 1-methyl (2S)-1,2-piperidinedicarboxylate | C12H21NO4 | 详情 | 详情 | |
| (XVI) | 38525 | 2-(tert-butyl) 1-methyl (2S)-6-oxo-1,2-piperidinedicarboxylate | C12H19NO5 | 详情 | 详情 | |
| (XVII) | 38526 | 2-(tert-butyl) 1-methyl (2S,5R)-5-methyl-6-oxo-1,2-piperidinedicarboxylate | C13H21NO5 | 详情 | 详情 | |
| (XVIII) | 38527 | 2-(tert-butyl) 1-methyl (2S,5R)-6-hydroxy-5-methyl-1,2-piperidinedicarboxylate | C13H23NO5 | 详情 | 详情 | |
| (XX) | 38530 | methyl (3R,6S,9R,9aR)-6-[(methoxycarbonyl)amino]-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C13H20N2O5S | 详情 | 详情 | |
| (XXI) | 38521 | methyl (3R,6S,9R,9aR)-6-amino-9-methyl-5-oxooctahydro[1,3]thiazolo[3,2-a]azepine-3-carboxylate | C11H18N2O3S | 详情 | 详情 |